Last Updated:
Name Designation Appointment Date Status
Heena Mayank Patel

Appointed as Director since April 2015

Director 01-Apr-2015 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Ajit Naginbhai Desai

Appointed as Director since March 2002

Director 28-Mar-2002 Current
Sheela Harish Merchant

Appointed as Director since September 2025

Director 01-Sep-2025 Current

People Timeline

Explore the timeline of key personnel in Sterkem Pharma Private Limited's leadership journey.

Loading...
Contact Details
  • Address S/3, Khira Indl Estate, B M Bhargoankar Road,, Santacruz West,, Mumbai Maharashtra, 400054, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Sterkem Pharma Private Limited?
You can contact Sterkem Pharma Private Limited through their registered address at S/3, Khira Indl Estate, B M Bhargoankar Road,, Santacruz West,, Mumbai Maharashtra, 400054, India, or via their website at sterkempharma.com. Social media links are also provided where applicable.
Who are the current directors of Sterkem Pharma Private Limited?
The current directors of Sterkem Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • HEENA MAYANK PATEL
  • AJIT NAGINBHAI DESAI
  • Sheela Harish Merchant
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available